Дізнайтеся про найкращі ціни та клініки з лікування дилатаційної кардіоміопатії у Італії у 2026 році

Italy offers elite cardiovascular care for dilated cardiomyopathy through IRCCS-accredited research hospitals. These centers specialize in advanced diagnostics and surgical interventions. High-volume facilities in Milan and Bologna provide genetic subtyping, mechanical heart support, and complex valve repairs with high success rates.

• San Donato Hospital: Italy's leading center performing over 9,400 cardiac operations annually in Milan.
• San Raffaele: European research hub specialized in advanced heart failure and mechanical circulatory support.
• Maria Cecilia Hospital: Handles over 15% of all Italian cardiac surgeries with JCI-accredited standards.
• Specialized diagnostics: Centers use cardiac MRI and genetic screening to personalize treatment pathways.

Bookimed Expert Insight: Patient volume is a primary indicator of quality for complex heart conditions in Italy. San Donato Hospital operates on 9,400 patients annually and maintains a 4.9 rating. This high volume often correlates with better outcomes in rare procedures like Micra pacemaker implants. Dr. Saverio Iacopino at Maria Cecilia Hospital was among Italy's first to use this technology.

Italian guidelines for dilated cardiomyopathy prioritize four drug pillars: ACE inhibitors or ARNI, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. The Italian Medicines Agency (AIFA) regulates these evidence-based therapies. Treatment often includes loop diuretics like furosemide for managing fluid retention.

• First-line pillars: Standard care includes beta-blockers, MRA, SGLT2 inhibitors, and ACE inhibitors or ARNI.
• Symptom management: Furosemide is the most frequent loop diuretic used for fluid retention.
• Secondary prevention: Acetylsalicylic acid is routinely prescribed to prevent secondary cardiovascular and cerebrovascular events.
• Regulatory oversight: AIFA uses Note 66 and the GRADE method to ensure therapeutic appropriateness.

Bookimed Expert Insight: While general practitioners oversee basic prescriptions, complex cardiomyopathy cases in Italy migrate toward specialized hubs. Maria Cecilia Hospital handles over 15% of national cardiac surgeries. This volume correlates with earlier access to advanced technologies like the Micra TPS leadless pacemaker, which Dr. Saverio Iacopino pioneered in Italy. Clinics with high surgical volumes often possess broader diagnostic infrastructure for nuanced heart failure management.

Patient Consensus: Patients note that treatment is usually framed as standard heart failure therapy. They emphasize that initial doses are often small, with slow titration required to manage side effects and blood pressure.

Italian specialists recommend devices when dilated cardiomyopathy patients meet specific thresholds. ICDs are used for secondary prevention after cardiac events. Primary prevention occurs if ejection fraction stays at 35% or lower after three months of medication. CRT requires electrical dyssynchrony and 130ms QRS duration.

• ICD primary prevention: Indicated for NYHA Class 2 or 3 symptomatic heart failure patients.
• ICD secondary prevention: Recommended for survivors of unstable ventricular tachycardia or cardiac arrest.
• CRT criteria: Required for wide QRS duration and symptomatic heart failure despite therapy.
• Mechanical support: Prescribed for advanced heart failure patients with peak oxygen below 14 units.

Bookimed Expert Insight: Italian centers like Maria Cecilia Hospital handle over 15% of national cardiac surgeries. This high volume allows specialists to prioritize advanced trials like the Protected TAVR study. Patients benefit because these institutions provide a multidisciplinary Heart Team approach. They often combine leadless pacemaker technology with traditional cardiac support protocols.

Patient Consensus: Patients note that doctors wait to confirm if medication improves heart function before suggesting devices. It is vital to bring current heart scans and medication lists to your first appointment.

Italy offers several advanced heart treatments for dilated cardiomyopathy. Patients can access innovative therapies like Enhanced External Counterpulsation (EECP) and ultra-small Micra TPS pacemakers. Leading research hospitals also provide compassionate use pathways for late-stage patients when standard cardiac protocols have been exhausted.

• Leadless technology: Micra TPS allows pacemaker implantation without surgical incisions or chest scars.
• 3D mapping: CardioInsight hi-tech jackets provide non-invasive, three-dimensional mapping of complex heart rhythms.
• Minimally invasive: Specialized Heart Teams perform transcatheter valve repairs to reduce cardiac workload.
• Research access: San Raffaele in Milan is a major European hub for experimental gene therapies.

Bookimed Expert Insight: Italian cardiology excellence is concentrated in high-volume clusters. Maria Cecilia Hospital alone manages over 15% of all cardiac surgeries in Italy. This massive patient volume allows surgeons like Dr. Saverio Iacopino to pioneer technologies like the Micra TPS. Choosing a clinic with IRCCS accreditation ensures you are at a facility recognized by the Ministry of Health for advanced research.

Family members should undergo clinical and genetic screening following a dilated cardiomyopathy diagnosis. This helps identify inherited risks before symptoms appear. Italian protocols prioritize first-degree relatives for electrocardiograms and echocardiograms. If a genetic mutation is identified in the patient, family members receive targeted testing.

• Clinical evaluation: Relatives receive echocardiograms and electrocardiograms to check heart pumping function.
• Genetic mapping: Testing identifies mutations in genes commonly associated with inherited cardiomyopathy.
• Cascade screening: Family members undergo targeted testing if a pathogenic variant is found.
• High-volume centers: San Donato Hospital performs over 9,400 heart operations annually for complex cases.

Bookimed Expert Insight: Italian cardiology excellence is concentrated in the Lombardy region, where hospitals like San Donato and San Raffaele handle massive patient volumes. Data shows Maria Cecilia Hospital manages over 15% of all cardiac surgeries in Italy. Patients should seek specialists like Dr. Saverio Iacopino, who pioneered Micra TPS implantation in Italy. These high-volume centers offer the most refined diagnostic accuracy for identifying subtle genetic indicators in family members.

Patient Consensus: Patients emphasize that a negative family history does not rule out genetic risks. They often note that specialized genetic counseling is essential when diagnosis occurs at an early age.